Work

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient

Year: 2019

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.02.004

Authors: Irene Ghobrial, Calixto Hernández Cruz, Alfred Garfall, Nina Shah, Nikhil Munshi, Jonathan Kaufman, Lawrence H. Boise, Gareth Morgan, Viktor A. Adalsteinsson, Salomon Manier, Rathi Pillai, Fabio Malavasi, Sagar Lonial

Institutions: Harvard University, Dana-Farber/Harvard Cancer Center, Hermanos Ameijeiras Hospital, University of Pennsylvania, University of California, San Francisco, Winship Cancer Institute, University of Arkansas Medical Center, University of Arkansas for Medical Sciences, Broad Institute, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, University of Turin

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Language Literacy and Culture, University of Maryland, Baltimore County, U.S. Department of Veterans Affairs, Amgen, Bristol-Myers Squibb, Pfizer, Merck, Novartis, Celgene, Takeda Pharmaceuticals U.S.A., European Hematology Association, National Cancer Institute, Janssen Pharmaceuticals

Awards: G2880310166, G3668218448, The Role of CD86 in Multiple Myeloma

OpenAlex ID: W2916974209

FWCI: 2.113

Cites: 152

Cited by: 17

Related to: 10